- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02723682
National Health and Nutrition Examination Survey 24-hour Urine Collection Feasibility Study, 2013
National Health and Nutrition Examination Survey 24-Hour Urine Collection Feasibility Study, 2013
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The 24-hour urine pilot study was conducted March - June 2013 in three NHANES locations. A random half-sample of non-pregnant US adults, aged 20-69 who were examined in the NHANES mobile examination center were selected. Participants received instructions, started and ended the urine collection in a urine study mobile examination center (UMEC), and answered questions about collection. A random half of participants who collected a complete 24-h urine were asked to collect a second 24-h urine. Urinary sodium, potassium, chloride, and creatinine excretion were analyzed.
Participation rates in two other post-examination components, the Physical Activity Monitor and the Dietary Recall, were monitored to determine whether collecting a 24-hour urine had an effect on response rates for the two components.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Maryland
-
Hyattsville, Maryland, Forenede Stater, 20782
- National Health and Nutrition Examination Survey
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- 20-69 year old adults examined in the NHANES mobile examination center
Exclusion Criteria:
- pregnant, unable to respond for themselves
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Tidsperspektiver: Tværsnit
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Study completion rates - initial collection
Tidsramme: 24 hours
|
Completion rate of initial 24-hour urine collection.
|
24 hours
|
|
Study completion rate - second collection
Tidsramme: 24 hours
|
Completion rate of second 24-hour urine collection
|
24 hours
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Response rates for the Physical Activity Monitor
Tidsramme: 24-hours
|
Response rates for the Physical Activity Monitor
|
24-hours
|
|
Response rates for the Phone Follow-up Dietary Recall
Tidsramme: 24-hours
|
Response rates for the Phone Follow-up Dietary Recall.
|
24-hours
|
|
Urine volume for the initial urine collection
Tidsramme: 24 hours
|
Urine volume adjusted to 24 hours, initial urine collection
|
24 hours
|
|
Urine volume for the second urine collection
Tidsramme: 24 hours
|
Urine volume adjusted to 24 hours, second urine collection
|
24 hours
|
|
Urinary sodium excretion for the initial urine collection
Tidsramme: 24 hours
|
24-hour urinary sodium excretion, initial urine collection
|
24 hours
|
|
Urinary sodium excretion for the second urine collection
Tidsramme: 24 hours
|
24-hour urinary sodium excretion, second urine collection
|
24 hours
|
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studieleder: Kathryn Porter, MD, MS, Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Health and Nutrition Examination Surveys
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2011-17
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Forhøjet blodtryk
-
VIVUS LLCIkke rekrutterer endnuPulmonal arteriel hypertension | Pulmonal arteriel hypertension (PAH) (WHO Group 1 PH) | Pulmonal arteriel hypertension (PAH) | Pulmonal arteriel hypertension WHO gruppe I | Pulmonal arteriel hypertension PAH
-
Philipps University MarburgMSD Sharp & Dohme GmbH, GermanyIkke rekrutterer endnu
-
BayerAfsluttet
-
National Taiwan University Hospital Hsin-Chu BranchRekrutteringHypertension, essentiel | Hypertension, maskeretTaiwan
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc...Ikke rekrutterer endnuPulmonal hypertension | Pulmonal arteriel hypertension (PAH)Forenede Stater
-
BackBeat Medical IncIkke rekrutterer endnuHypertension, systolisk | Hypertension (HTN) | Hjertesvigt med bevaret ejektionsfraktion (HFpEF)Georgien
-
Stanford UniversityNational Heart, Lung, and Blood Institute (NHLBI); University of MichiganIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Forenede Stater
-
University of Sao Paulo General HospitalRekrutteringPulmonal arteriel hypertension (PAH)Brasilien
-
University Hospital, BrestIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)Frankrig
-
Shanghai Zhongshan HospitalIkke rekrutterer endnuPulmonal arteriel hypertension (PAH)
Kliniske forsøg med Collect 24-hour urine specimen
-
Ocular Therapeutix, Inc.Afsluttet
-
Zhiming ZhuAfsluttetForhøjet blodtryk | Primær aldosteronismeKina
-
Johns Hopkins UniversityAfsluttetRygsmerte | LændesmerterForenede Stater
-
University Hospital, ToursAfsluttetTuberøs sklerosekompleks | LymfangioleiomyomatoseFrankrig
-
Institut de Myologie, FranceAfsluttet
-
Pennington Biomedical Research CenterAfsluttetInsulinfølsomhedForenede Stater
-
Assiut UniversityIkke rekrutterer endnuKlinisk resultat i WILSONs sygdom
-
Halil Ata BIÇAKÇIOGLUAfsluttetParadentose | Kronisk paradentose (lidelse)Tyrkiet (Türkiye)
-
NHS Greater Glasgow and ClydeUniversity of Glasgow; Roche Diagnostics GmbHRekrutteringKardiomyopatier | Genetisk disposition | Kardiomyopati, PrimærDet Forenede Kongerige